Gelteq Valuation Multiples

Gelteq Overview

About Gelteq

Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.

Founded

2018

HQ

Employees

18

Website

gelteq.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: $115K

EBITDA: ($2M)

EV

$11M

Valuation Multiples

Multiples.vc

Start free trial

Gelteq Financials

Gelteq reported last fiscal year revenue of $115K and negative EBITDA of ($2M).

In the same fiscal year, Gelteq generated ($2M) in EBITDA losses and had net loss of ($5M).

Gelteq P&L

In the most recent fiscal year, Gelteq reported revenue of $115K and EBITDA of ($2M).

Gelteq expects next 12-month revenue of XXX and NTM EBITDA of XXX

Gelteq Stock Performance

Gelteq has current market cap of $8M, and enterprise value of $11M.

Gelteq's stock price is $0.76.

Gelteq Valuation Multiples

Gelteq trades at 94.8x EV/Revenue multiple, and (4.5x) EV/EBITDA.

Gelteq Financial Valuation Multiples

As of April 10, 2026, Gelteq has market cap of $8M and EV of $11M.

Equity research analysts estimate Gelteq's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Gelteq has a P/E ratio of (1.8x).

Gelteq Margins & Growth Rates

Gelteq's revenue in the last fiscal year grew by 100%.

Gelteq's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.

Gelteq Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Gelteq M&A Activity

Gelteq acquired XXX companies to date.

Last acquisition by Gelteq was on XXXXXXXX, XXXXX. Gelteq acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Gelteq Investment Activity

Gelteq invested in XXX companies to date.

Gelteq made its latest investment on XXXXXXXX, XXXXX. Gelteq invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).